Available Technologies

Browse Penn-owned technologies available for licensing.


Search Results - tejvir khurana

4 Results Sort By:
Up-regulators of utrophin expression for the treatment of muscular dystrophy
Small molecules targeting utrophin mRNA untranslated regions overcome post-transcriptional repression Problem: Duchenne Muscular Dystrophy (DMD) is an X-linked neuromuscular disorder that affects approximately 1 in 3500 males worldwide. DMD is caused by mutations in the DMD gene that lead to severe reduction or loss of dystrophin protein. Without appropriate...
Published: 4/28/2020   |   Inventor(s): Tejvir Khurana, Donna Huryn
Keywords(s): Drug Target, Genetic Disorders, Musculoskeletal
Category(s): Therapeutics & Vaccines
Small molecule utrophin up-regulators for treatment of muscular dystrophy
Technology Overview: Duchenne muscular dystrophy (DMD) is a recessive X-linked form of muscular dystrophy affecting 1 in 3,600 boys, and is caused by mutations in the dystrophin gene. DMD leads to progressive muscle degeneration and eventually death. Many strategies have been proposed and are being studied for treatment of DMD and other more rare...
Published: 3/11/2020   |   Inventor(s): Tejvir Khurana, Catherine Moorwood
Category(s): Therapeutics & Vaccines
Gene therapy for treatment of Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular Dystrophy (DMD) therapy deletes let-7c miRNA binding sites using CRISPR-Cas9 based genome editing and AAV based delivery. Problem: Duchenne Muscular Dystrophy (DMD) is a fatal disease characterized by progressive muscle degeneration and weakness that affects 1 in 3,500 live-born males worldwide, and which ultimately causes death...
Published: 2/13/2020   |   Inventor(s): Tejvir Khurana
Category(s): Therapeutics & Vaccines
Therapeutic Approach for Treatment of Duchenne Muscular Dystrophy
Technology Overview: Duchenne Muscular Dystrophy (DMD) is the most common X-linked fatal neuromuscular disorder, affecting approximately 1 in every 3500 male births. It is characterized by progressive degeneration of skeletal and cardiac muscle due to a defective form of the gene dystrophin. There is currently no cure for DMD and the available treatment...
Published: 1/28/2020   |   Inventor(s): Tejvir Khurana
Category(s): Therapeutics & Vaccines